Material Safety Data Sheet Section 1. Identification of the substance Product Name: 1-Bromo-4-chloro-2-iodobenzene Synonyms: Section 2. Hazards identification Harmful by inhalation, in contact with skin, and if swallowed. Section 3. Composition/information on ingredients. Ingredient name: 1-Bromo-4-chloro-2-iodobenzene CAS number: 148836-41-3 Section 4. First aid measures Skin contact: Immediately wash skin with copious amounts of water for at least 15 minutes while removing contaminated clothing and shoes. If irritation persists, seek medical attention. Eye contact: Immediately wash skin with copious amounts of water for at least 15 minutes. Assure adequate flushing of the eyes by separating the eyelids with fingers. If irritation persists, seek medical attention. Inhalation: Remove to fresh air. In severe cases or if symptoms persist, seek medical attention. Ingestion: Wash out mouth with copious amounts of water for at least 15 minutes. Seek medical attention. Section 5. Fire fighting measures In the event of a fire involving this material, alone or in combination with other materials, use dry powder or carbon dioxide extinguishers. Protective clothing and self-contained breathing apparatus should be worn. Section 6. Accidental release measures Personal precautions: Wear suitable personal protective equipment which performs satisfactorily and meets local/state/national standards. Respiratory precaution: Wear approved mask/respirator Hand precaution: Wear suitable gloves/gauntlets Skin protection: Wear suitable protective clothing Eye protection: Wear suitable eye protection Methods for cleaning up: Mix with sand or similar inert absorbent material, sweep up and keep in a tightly closed container for disposal. See section 12. Environmental precautions: Do not allow material to enter drains or water courses. Section 7. Handling and storage Handling: This product should be handled only by, or under the close supervision of, those properly qualified in the handling and use of potentially hazardous chemicals, who should take into account the fire, health and chemical hazard data given on this sheet. Store in closed vessels, refrigerated. Storage: Section 8. Exposure Controls / Personal protection Engineering Controls: Use only in a chemical fume hood. Personal protective equipment: Wear laboratory clothing, chemical-resistant gloves and safety goggles. General hydiene measures: Wash thoroughly after handling. Wash contaminated clothing before reuse. Section 9. Physical and chemical properties Appearance: Not specified Boiling point: No data No data Melting point: Flash point: No data Density: No data Molecular formula: C6H3BrClI Molecular weight: 317.3 Section 10. Stability and reactivity Conditions to avoid: Heat, flames and sparks. Materials to avoid: Oxidizing agents. Possible hazardous combustion products: Carbon monoxide, hydrogen chloride, hydrogen bromide, hydrogen Iodide. Section 11. Toxicological information No data. Section 12. Ecological information No data. Section 13. Disposal consideration Arrange disposal as special waste, by licensed disposal company, in consultation with local waste disposal authority, in accordance with national and regional regulations. Section 14. Transportation information Non-harzardous for air and ground transportation. Section 15. Regulatory information No chemicals in this material are subject to the reporting requirements of SARA Title III, Section 302, or have known CAS numbers that exceed the threshold reporting levels established by SARA Title III, Section 313.
scaffolds—ortho‐orientated terphenyls presenting twoatropisomeric Ar–Ar axes. These unusual structures were built up by using the C−Hactivation approach, and remarkably, both chiral axes were controlled with excellent stereoselectivity in a single transformation. During the reaction, not only does atroposelective functionalization of a biaryl precursor occur to establish one stereogenic axis, but an
Rapid Access to Dibenzohelicenes and their Functionalized Derivatives
作者:Andrej Jančařík、Jiří Rybáček、Kevin Cocq、Jana Vacek Chocholoušová、Jaroslav Vacek、Radek Pohl、Lucie Bednárová、Pavel Fiedler、Ivana Císařová、Irena G. Stará、Ivo Starý
DOI:10.1002/anie.201301739
日期:2013.9.16
Spiraling up: Easy access to dibenzo[5]‐, dibenzo[6]‐, and dibenzo[7]helicenes (see picture) as well as their functionalizedderivatives includes Sonogashira and Suzuki–Miyaura couplings, desilylation, and [2+2+2] alkyne cycloisomerization. The simplicity of this non‐photochemical approach combined with the potential for helicity control favors dibenzohelicenes over the parent helicenes for practical
9-Silafluorenyl Dichlorides as Chemically Ligating Coupling Agents and Their Application in Peptide Synthesis
作者:Samuel J. Aspin、Sylvain Taillemaud、Patrick Cyr、André B. Charette
DOI:10.1002/anie.201606120
日期:2016.10.24
A fundamentally simple, mild, and practicalprocedure for peptide bond formation is reported that employs a stoichiometric amount of easy‐to‐access 9‐silafluorenyl dichlorides as the coupling agent. Without initial preactivation or elaboration of the carboxylic acid or amine termini of the amino acids, the developed reagent is proposed to act through an unprecedented chemical ligation mechanism, bringing
A Pd-catalyzed optional approach for the synthesis of dibenzothiophenes
作者:Juan Song、Hao Wu、Wei Sun、Songjiang Wang、Haisen Sun、Kang Xiao、Yan Qian、Chao Liu
DOI:10.1039/c8ob00235e
日期:——
A direct and practical approach for the construction of DBTs was developed via a Pd-catalyzed tandem reaction, in which commercially available o-bromo-iodobenzenes combined with benzene thiols or iodobenzenes combined with o-bromo-benzene thiols were applied. These two approaches will provide an alternative for the synthesis of DBT derivatives.
[EN] FACTOR XIA INHIBITORS<br/>[FR] INHIBITEURS DU FACTEUR XIA
申请人:MERCK SHARP & DOHME
公开号:WO2015183709A1
公开(公告)日:2015-12-03
The present invention provides a compound of Formula I(The chemical formula should be inserted here.) and pharmaceutical compositions comprising one or more said compounds, and methods for using said compounds for treating or preventing thromboses, embolisms, hypercoagulability or fibrotic changes. The compounds are selective Factor XIa inhibitors or dual inhibitors of Factor XIa and plasma kallikrein.